FDA approved an expanded indication for ENBREL (etanercept) to inhibit progression of structural damage of active arthritis
On Aug. 25, 2003, the FDA approved an expanded indication for ENBREL (etanercept) to inhibit the progression of…
On Aug. 25, 2003, the FDA approved an expanded indication for ENBREL (etanercept) to inhibit the progression of…
On Jul. 17, 2003, the results from the Prostate Cancer Prevention Trial (PCPT) were published in New England…
On Jul. 8, 2003, the U.S. Centers for Disease Control and Prevention (CDC) responded to U.S. outbreak of…
On May 13, 2003, the FDA approved the drug bortezomib (Velcade) for the treatment of multiple myeloma. In…
On Apr. 24, 2003, the National Cancer Institute, CDC, AHRQ, and SAMHSA, in collaboration with the American Cancer…
On Apr. 23, 2003, Dr. Vincent Poitout at the Pacific Northwest Research Foundation (PNRF) won the Thomas R….
In Sept. 2003, Emory’s Winship Cancer Institute opened a new, 280,000-square-foot, state-of-the-art facility, adding new research and high-tech…
In Jan. 2003, the Arizona Nanotechnology Cluster, an Arizona not-for-profit organization, was formed to share technological advances, and…
In 2003, the U.S. Environmental Protection Agency (EPA) approved the first transgenic rootworm-resistant corn developed by Monsanto under…
In 2003, over 1,000 of NNMC’s medical staff members deployed on the USNS COMFORT serving in the Persian…
On Dec. 24, 2002, the FDA’s Office of Combination Products was formed within the Office of the Commissioner,…
On Oct. 31, 2002, National Cancer Institute (NCI) researchers announced they had discovered that a molecule best known…
On Oct. 26, 2002, under the Medical Device User Fee and Modernization Act, fees are assessed sponsors of…
On Oct. 16, 2002, patterns of proteins found in patients’ blood may help distinguish between prostate cancer and…
On Sept. 19, 2002, a new approach to cancer treatment that replaced a patient’s immune system with cancer-fighting…
On Aug. 21, 2002, the FDA announced an initiative to modernize the regulation of pharmaceutical manufacturing and product…
On Aug. 21, 2002, the FDA announced an effort to enhance and update the regulation of manufacturing processes…
On Jul. 3, 2002, Dr. Julie Louise Gerberding, M.D., M.P.H., became the first woman Director of the Centers…
On Jul. 2, 2002, the University of California, Davis Comprehensive Cancer Center announced it had received National Cancer…
On Feb. 28, 2002, the FDA announced it had licensed the first nucleic acid test (NAT) system intended…
On Jan. 4, 2002, President George W. Bush signed P.L. 107-109 – S. 1789, the Best Pharmaceuticals for…
On Jan. 4, 2002, The Best Pharmaceuticals for Children Act was signed into law, established a process for…
In 2002, Stanford researchers became the first to use RNAi to switch off genes in mice.
In 2002, Soy Creations, A Division of Triple ‘F’ Inc, and a corporate partner of Iowa State University’s …
In 2002, the Penn Medicine’s Cancer Center was renamed the Abramson Cancer Center of the University of Pennsylvania…
In 2002, the Vanderbilt Institute of Chemical Biology (VICB) was founded at the Vanderbilt School of Medicine to…
On Jul. 30, 2002, Dr. R. Paul Robertson, President and Scientific Director at the Pacific Northwest Research Foundation…
On Nov. 28, 2001, researchers discovered the E6 and E7 gene in HPV virus, linking cervical cancer cell…
In 2001, K. Barry Sharpless, of The Scripps Research Institute in La Jolla, CA, was awarded the Nobel…
In 2001, Oregon Health Sciences Center’s name changed to Oregon Health & Science University (OHSU) as Governor John…